 NEW YORK, July 7, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Citius Pharmaceuticals, Inc. Citrus or the Company NASDAQ: CTXR. Such investors are advised to contact Robert S. 